Circuit Bio is developing logical gene circuits for cancer immunotherapy.
Synthetic gene circuits specifically targeting cancer cells are expected to produce multiple immunomodulators, which will be expressed exclusively in the target tumor cells. The circuit will lead to the triggering of a robust long-term anti-tumoral immune response.
Breast cancer, CRC
Lior Nissim, PhD, Inventor
Nir Skalka, PhD, CSO